Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments


May 2009
Biopharmaceutical company Hybrigenics, based in Paris, has signed a contract as part of the European Union research project Masterswitch. The company will receive more than €400,000 over the first two years of the five-year agreement, which will enable it to develop a high-throughput assay and attempt to identify small-molecule inhibitors of a protein reaction found in chronic inflammatory diseases.

BiophotonicsHybrigenicsMasterswitchNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.